Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neuropsychopharmacology Reports|July 13, 2021
SSRIs: Applications in inflammatory lung disease and implications for COVID-19Claire Kyung Sun Meikle, Justin Fortune Creeden, Cheryl McCullumsmith, et al.
CNS Spectrums|July 17, 2025
From betel nuts to Cobenfy: how an ancient recreational drug gave rise to a new class of schizophrenia medicationsJustin Fortune Creeden, Siddharth M Machiraju, Johansen B Amin, et al.
Molecules (Basel, Switzerland)|March 11, 2023
Emerging Immunotherapeutic and Diagnostic Modalities in Carcinoid TumorsShahnaz D Vellani, Anthony Nigro, Shangari Varatharajan, et al.
Bioimpacts : BI|November 29, 2023
The application, safety, and future of <i>ex vivo</i> immune cell therapies and prognosis in different malignanciesKatelyn R Einloth, Scott Gayfield, Thomas McMaster, et al.
Current Problems in Cancer|December 12, 2022
Folate Receptor as a Biomarker and Therapeutic Target in Solid TumorsOlivia Young, Nealie Ngo, Leslie Lin, et al.
Future Oncology (London, England)|February 27, 2020
Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatmentSusan Morand, Hannah Staats, Justin Fortune Creeden, et al.
Scientific Reports|October 15, 2022
Subcellular partitioning of protein kinase activity revealed by functional kinome profilingLauren Wegman-Points, Khaled Alganem, Ali Sajid Imami, et al.
BMC Cancer|October 29, 2021
Homologous recombination proficiency in ovarian and breast cancer patientsJustin Fortune Creeden, Nisha S Nanavaty, Katelyn R Einloth, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2021
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infectionJustin Fortune Creeden, Ali Sajid Imami, Hunter M Eby, et al.
Scientific Reports|February 25, 2021
Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSinead M O'Donovan, Ali Imami, Hunter Eby, et al.
Pageof 1